Dr. Joel S. Levine is a consultant and subject matter expert for the NASA Engineering and Safety Center in the areas of space and planetary environments. Dr. Levine worked for NASA from 1970 to 2011 ...

Hair parted in the middle, cropped at the back, with a wavy lock styled above one ear. That’s not my haircut of choice, but if you were an elite Viking, it may well have been. That’s the upshot of a ...

EXCLUSIVE: Oscar-winning Danish director Anders Thomas Jensen lands in Venice this weekend with dark comedy The Last Viking, reuniting him with actors Mads Mikkelsen and Nikolaj Lie Kaas who have ...

Denmark's National Museum has unveiled what it described as the first "portrait" of a Viking: a miniature 10th-century figurine depicting a man with an imperial moustache, braided beard and ...

Archaeologists in Norway surveyed an area exposed by melting ice and found fragments of an “extraordinary” Viking cargo net, photos show. Photo from Secrets of the Ice As the late summer sun beat down ...

Aug 19 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a mid-stage trial, missing Wall ...

A Viking Therapeutics drug that hits two targets to spark weight loss achieved the goals of a closely watched mid-stage clinical trial, but with results that also show many patients stopped the ...

Viking Therapeutics Inc. on Tuesday announced that a trial showed its oral weight-loss drug works — and like a larger rival, its stock price immediately suffered. Steven Goldstein is based in London ...

Viking has taken delivery of its newest purpose-built Nile River ship this week, the Viking Amun. The delivery ceremony for the line’s seventh Egypt ship was held at Massara shipyard in Cairo, Egypt.

Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage study, marking another weaker-than-expected result for an oral alternative ...

Viking Therapeutics' new GLP-1 weight loss pill, VK2735, helped patients shed 12.2% of their body weight in 13 weeks. The pill is proving "safe and well-tolerated." However, one-fifth of participants ...

Viking Therapeutics presents a high-risk, high-reward opportunity in the exploding GLP-1 weight loss market, where early clinical data for its VK2735 drug shows competitive results against current ...